PUBLICACIÓN
Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity.
Llerena A, Dorado P, Peñas-Lledó EM
2009
DOI
10.2217/14622416.10.1.17
AUTORES DE LA UEX
PUBLICACIÓN
Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity.
Llerena A, Dorado P, Peñas-Lledó EM
2009
DOI
10.2217/14622416.10.1.17
AUTORES DE LA UEX
